COMMUNIQUÉS West-GlobeNewswire

Zogenix to Release Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on February 28
21/02/2019
EMERYVILLE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the [...]
GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference
21/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 8th Annual SVB Leerink Global Healthcare Conference in New [...]
Chiesi Joins National Organization for Rare Disorders (NORD)® Corporate Council
21/02/2019
Partnership supports Chiesi USA presence in global rare disease market CARY, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee), a specialty pharmaceutical company, and the National Organization for Rare [...]
Intra-Cellular Therapies to Present at the 8th Annual SVB Leerink Global Healthcare Conference
21/02/2019
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Achaogen Announces Publication of Plazomicin Phase 3 CARE Study Results in the New England Journal of Medicine
21/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]
Axovant to Host First R&D Day March 29, 2019
21/02/2019
NEW YORK and BASEL, Switzerland, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that it will host its first R&D Day [...]
AlloSure now available for Lung Transplant Patients
21/02/2019
New data highlights the value of AlloSure to detect rejection in one of the most complex transplanted organs BRISBANE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics [...]
Sienna Announces 2019 Annual and Special Meeting
21/02/2019
MARKHAM, Ontario, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) today announced that it will be hosting its 2019 annual and special meeting of shareholders on [...]
Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
21/02/2019
First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trials A therapeutic vaccine may represent a novel approach for early treatment and [...]
Melinta Therapeutics Announces One-for-Five Reverse Stock Split
21/02/2019
NEW HAVEN, Conn., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]
SuperSonic Imagine will present its Aixplorer® MACH 30 ultrasound system at the 25th European Congress of Radiology (ECR 2019)
21/02/2019
in Vienna, Austria, from 27 February to 3 March 2019 AIX-EN-PROVENCE, France, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialising in ultrasound [...]
SuperSonic Imagine présentera son échographe Aixplorer® MACH 30 lors de la 25ème édition du Congrès Européen de Radiologie (ECR) 2019
21/02/2019
à Vienne en Autriche du 27 février au 3 mars 2019 AIX-EN-PROVENCE, France, 21 févr. 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, éligible PEA-PME), société spécialisée dans l’imagerie [...]
VitalHub Announces Intention to Enter the Patient Flow Market Through Acquisition Strategy
21/02/2019
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that it has imminent plans to enter the rapidly growing global patient flow market through a [...]
iCAD to Showcase ProFound AI™ Solution for Digital Breast Tomosynthesis at ECR 2019
21/02/2019
Currently pending CE Mark, ProFound AI technology for 2D mammography will also be previewed NASHUA, N.H., Feb. 21, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing [...]
AroCell AB (publ) Year-End Report 2018
21/02/2019
Word from the CEO ”2018 has been an exciting year for AroCell with several major events. In April, AroCell signed a global non-exclusive license agreement with F. Hoffmann-La Roche Ltd (Roche). Roche is the market [...]
Ossur Hf : Final agenda and proposals for the Annual General Meeting 7 March 2019
21/02/2019
Announcement no. 12/2019 21 February 2019 Final agenda and proposals Enclosed is the final agenda and proposals for Össur's Annual General Meeting to be held on Thursday 7 March 2019. The meeting will be held at Össur's [...]
Saniona publishes its year-end report for 2019
21/02/2019
PRESS RELEASE February 21, 2019 Financial highlights Jan – Dec 2018 (Jan - Dec 2017) Net revenues were SEK 54.9 M (20.7 M) EBIT was SEK -54.2 M (-57.2 M) Net profit/loss was SEK -41.1 M (-49.2) Earnings per share were [...]
VALNEVA Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019
21/02/2019
Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 Major R&D milestones achieved in 2018, double-digit product sales revenue growth delivered; Lyme and chikungunya [...]
VALNEVA publie de très bons résultats 2018, prévoit une poursuite de la croissance et des avancées R&D importantes en 2019
21/02/2019
Valneva publie de très bons résultats 2018, prévoit une poursuite de la croissance et des avancées R&D importantes en 2019 Avancées R&D majeures et croissance à deux chiffres du chiffre d'affaires des ventes de [...]

Pages